Historical record - last NADAC effective date: 2/22/2017
Product Information
LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0370 per EA under NDC 65862004405. Its NADAC has been published 170 times since Nov 28, 2013.
FDA first approved this application on Mar 14, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Lisinopril and Hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5; 20 mg/1; mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862004405
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
2/22/2017
Active Ingredients
HYDROCHLOROTHIAZIDE; LISINOPRILApproval Type
Generic (ANDA)
FDA Application
ANDA077606FDA Approved
3/14/2006
TE Code
AB
On Market Since
3/14/2006
Pharmacological Classes
Price Statistics
The NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has been published 170 times since Nov 28, 2013, and over the history we have for it it has declined 13.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0370 per EA |
|---|---|
| All-time high | $0.0461 (Apr 16, 2014) |
| All-time low | $0.0328 (Jun 22, 2016) |
| Median price | $0.0370 |
| Average price | $0.0387 |
| Largest weekly change | -9.7% (Nov 23, 2016) |
| Weeks tracked | 170 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-13.2%
Last surveyed Feb 22, 2017 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, manufactured by Aurobindo Pharma Limited, is $0.0370 per EA (NDC 65862004405), effective Feb 22, 2017.
How has the price of LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB changed over time?
Over the history we have for it, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has declined 13.2%. It has been tracked across 170 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
Since Nov 28, 2013, the NADAC for LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB has ranged from a low of $0.0328 (Jun 22, 2016) to a high of $0.0461 (Apr 16, 2014), with a median of $0.0370 per EA.
Are there cheaper alternatives to LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB, is $0.0366 per EA — about 1% below LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB.
Who manufactures LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB?
LISINOPRIL-HYDROCHLOROTHIAZIDE 20-12.5 MG TAB (NDC 65862004405) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.